Adoptive cellular immunotherapy: NK cells and bone marrow transplantation

Area of Science:

• Immunology and Hematology
• Transplantation Medicine

Background:

• Allogeneic bone marrow transplantation (BMT) is a vital treatment for various disorders but faces significant challenges.
• Key obstacles include graft-versus-host disease (GVHD), tumor relapse, and opportunistic infections due to immunosuppression.
• Current strategies to mitigate GVHD can increase relapse rates, while enhancing anti-tumor effects may worsen GVHD.

Purpose of the Study:

• To evaluate the potential of natural killer (NK) cells in overcoming major obstacles associated with allogeneic BMT.
• To explore the mechanisms by which NK cells may improve BMT outcomes.

Main Methods:

• Review of existing literature on the role of NK cells in the context of allogeneic BMT.
• Analysis of NK cell functions, including their effects on hematopoiesis, GVHD, graft-versus-tumor (GVT) effects, and B cell recovery.

Main Results:

• NK cells can promote hematopoiesis and engraftment through hematopoietic growth factor production.
• NK cells demonstrate a capacity to reduce the incidence and severity of GVHD, partly via TGF-beta.
• NK cells exhibit anti-tumor effects in animal models, suggesting a role in GVT responses, and influence B cell recovery.

Conclusions:

• Adoptive immunotherapy with NK cells offers potential advantages for allogeneic BMT.
• NK cells may simultaneously address GVHD, engraftment failure, and tumor relapse.
• Further understanding of NK cell mechanisms post-BMT could significantly enhance treatment efficacy.